Nikko Asset Management Americas’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-60,070
| Closed | -$1.73M | – | 192 |
|
|
2023
Q4 | $1.73M | Sell |
60,070
-2,929
| -5% | -$88.5K | 0.02% | 144 |
|
|
2023
Q3 | $2.09M | Sell |
62,999
-1,500
| -2% | -$53K | 0.03% | 142 |
|
|
2023
Q2 | $2.37M | Buy |
64,499
+3,020
| +5% | +$118K | 0.02% | 141 |
|
|
2023
Q1 | $2.5M | Sell |
61,479
-4,679
| -7% | -$202K | 0.03% | 139 |
|
|
2022
Q4 | $3.39M | Sell |
66,158
-4,818
| -7% | -$231K | 0.05% | 130 |
|
|
2022
Q3 | $3.13M | Buy |
70,976
+180
| +0.3% | +$8.75K | 0.04% | 132 |
|
|
2022
Q2 | $3.7M | Sell |
70,796
-153,101
| -68% | -$7.8M | 0.05% | 130 |
|
|
2022
Q1 | $11.6M | Sell |
223,897
-26,950
| -11% | -$1.4M | 0.09% | 98 |
|
|
2021
Q4 | $14.9M | Sell |
250,847
-104,927
| -29% | -$5.2M | 0.08% | 98 |
|
|
2021
Q3 | $15.1M | Buy |
+355,774
| New | +$15.8M | 0.06% | 107 |
|
|
2018
Q3 | – | Sell |
-17,452
| Closed | -$601K | – | 175 |
|
|
2018
Q2 | $601K | Sell |
17,452
-155,020
| -90% | -$5.3M | 0.02% | 151 |
|
|
2018
Q1 | $5.81M | Sell |
172,472
-181,504
| -51% | -$6.24M | 0.21% | 90 |
|
|
2017
Q4 | $12M | Hold |
353,976
| – | – | 0.31% | 81 |
|
|
2017
Q3 | $12M | Sell |
353,976
-15,810
| -4% | -$508K | 0.59% | 67 |
|
|
2017
Q2 | $11.8M | Buy |
369,786
+74,728
| +25% | +$2.36M | 0.7% | 49 |
|
|
2017
Q1 | $9.58M | Buy |
295,058
+221,762
| +303% | +$6.99M | 0.71% | 44 |
|
|
2016
Q4 | $2.26M | Buy |
73,296
+15,599
| +27% | +$476K | 0.18% | 81 |
|
|
2016
Q3 | $1.85M | Buy |
57,697
+12,964
| +29% | +$433K | 0.16% | 79 |
|
|
2016
Q2 | $1.49M | Sell |
44,733
-71,356
| -61% | -$2.28M | 0.14% | 88 |
|
|
2016
Q1 | $3.31M | Buy |
116,089
+4,638
| +4% | +$132K | 0.4% | 63 |
|
|
2015
Q4 | $3.46M | Buy |
111,451
+16,969
| +18% | +$534K | 0.39% | 61 |
|
|
2015
Q3 | $2.78M | Buy |
94,482
+34,572
| +58% | +$1.11M | 0.29% | 72 |
|
|
2015
Q2 | $1.91M | Buy |
59,910
+22,977
| +62% | +$749K | 0.13% | 92 |
|
|
2015
Q1 | $1.23M | Hold |
36,933
| – | – | 0.1% | 98 |
|
|
2014
Q4 | $1.1M | Sell |
36,933
-4,005
| -10% | -$115K | 0.08% | 106 |
|
|
2014
Q3 | $1.16M | Sell |
40,938
-29,196
| -42% | -$819K | 0.07% | 104 |
|
|
2014
Q2 | $1.98M | Buy |
70,134
+22,134
| +46% | +$631K | 0.1% | 81 |
|
|
2014
Q1 | $1.45M | Sell |
48,000
-12,227
| -20% | -$365K | 0.07% | 95 |
|
|
2013
Q4 | $1.75M | Sell |
60,227
-34,465
| -36% | -$1M | 0.07% | 96 |
|
|
2013
Q3 | $2.6M | Sell |
94,692
-2,108
| -2% | -$57.4K | 0.09% | 74 |
|
|
2013
Q2 | $2.59M | Buy |
+96,800
| New | +$2.67M | 0.08% | 71 |
|
Other funds holding PFE
Nikko Asset Management Americas's PFE Position: Q1 2024 in Review
Nikko Asset Management Americas sold out of Pfizer (PFE) in Q1 2024, closing a stake of 60,070 shares — an estimated $1.73M sold.
Nikko Asset Management Americas first reported a position in PFE in Q2 2013 and held it in 31 quarters. The position peaked at $15.1M in Q3 2021. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Nikko Asset Management Americas reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- Nikko Asset Management Americas sold 60,070 Pfizer shares in Q1 2024, an estimated $1.73M.
- Nikko Asset Management Americas first reported a position in Pfizer in Q2 2013 and held it in 31 quarters.
- Nikko Asset Management Americas's Pfizer position peaked at $15.1M in Q3 2021.
- 2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Nikko Asset Management Americas's 13F filing for Q1 2024, filed 2 May 2024.